GAM
GEM Asset Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $873K | Buy |
4,655
+18
| +0.4% | +$3.38K | 0.45% | 38 |
|
2025
Q1 | $956K | Sell |
4,637
-17
| -0.4% | -$3.51K | 0.54% | 34 |
|
2024
Q4 | $827K | Buy |
4,654
+27
| +0.6% | +$4.8K | 0.46% | 36 |
|
2024
Q3 | $896K | Buy |
4,627
+3
| +0.1% | +$581 | 0.51% | 36 |
|
2024
Q2 | $793K | Buy |
4,624
+3
| +0.1% | +$515 | 0.49% | 34 |
|
2024
Q1 | $759K | Buy |
4,621
+3
| +0.1% | +$493 | 0.51% | 35 |
|
2023
Q4 | $716K | Sell |
4,618
-196
| -4% | -$30.4K | 0.5% | 34 |
|
2023
Q3 | $718K | Buy |
4,814
+4
| +0.1% | +$596 | 0.57% | 32 |
|
2023
Q2 | $648K | Sell |
4,810
-51
| -1% | -$6.87K | 0.5% | 32 |
|
2023
Q1 | $775K | Sell |
4,861
-113
| -2% | -$18K | 0.63% | 30 |
|
2022
Q4 | $804K | Buy |
+4,974
| New | +$804K | 0.69% | 27 |
|